Approval for the addition of the advia centaur xp instrument (with version 5.0software) to the instrument(s) using the advia centaur psa assay. the device, as modified, will be marketed under the trade name advia centaur and advia centaur xp psa assay and isindicated for the measurement of serum psa in conjunction with digital rectal exam (dre) as an aid in the detection of prostate cancer in men aged 50 years and older. prostate biopsy is required for the diagnosis of prostate cancer. this assay is further indicated as an aid in the management (monitoring) of patients with prostate cancer.